Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Early-access Avacopan in Real-world ANCA-associated Vasculitis

View source ↗

Summary

This entry provides information about an early-access program for avacopan in real-world ANCA-associated vasculitis, and notes that the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAVNEOS (avacopan)

Snippet

Sponsor: Leiden University Medical Center | Conditions: ANCA Associated Vasculitis | Status: RECRUITING